Published in Medical Letter on the CDC and FDA, January 14th, 2007
The deal gives Possis 15% ownership in Rafael Medical with a three-year option to purchase the company, together with an obligation to provide up to $1.5 million of secured debt financing and one seat on Rafael's board of directors. Rafael Medical is developing its proprietary SafeFlo inferior vena cava (IVC) filter. It is estimated that by 2010, the U.S. market for IVC filters will total nearly $200 million.
The inferior vena cava (IVC) is the large vein that carries de-oxygenated blood from the lower body back to the heart and then to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA